{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:07:58Z","timestamp":1776431278080,"version":"3.51.2"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/04326\/2025"],"award-info":[{"award-number":["UID\/04326\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/PRR\/04326\/2025"],"award-info":[{"award-number":["UID\/PRR\/04326\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0101\/2020"],"award-info":[{"award-number":["LA\/P\/0101\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejmcr.2026.100335","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:28:37Z","timestamp":1774052917000},"page":"100335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Expanding the role of thiophilic metallodrugs in antiparasitic chemotherapy: multi-target approaches against protozoan parasites"],"prefix":"10.1016","volume":"17","author":[{"given":"In\u00eas C.C.","family":"Costa","sequence":"first","affiliation":[]},{"given":"Philippe M.","family":"Loiseau","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9447-2855","authenticated-orcid":false,"given":"Maria L.S.","family":"Cristiano","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6914-7957","authenticated-orcid":false,"given":"Sandrine","family":"Cojean","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.ejmcr.2026.100335_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/ced.14919","article-title":"Treatment options for leishmaniasis","volume":"47","author":"Pradhan","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1052478","article-title":"Leishmaniasis: recent epidemiological studies in the Middle East","volume":"13","author":"Knight","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","article-title":"A review of leishmaniasis: current knowledge and future directions","volume":"8","author":"Mann","year":"2021","journal-title":"Curr. Trop. Med. Reports"},{"key":"10.1016\/j.ejmcr.2026.100335_bib4","series-title":"WHO | World Health Organization","year":"2025"},{"key":"10.1016\/j.ejmcr.2026.100335_bib5","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","volume":"2011","author":"Haldar","year":"2011","journal-title":"Mol. Biol. Int."},{"key":"10.1016\/j.ejmcr.2026.100335_bib6","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.3390\/ijerph7124267","article-title":"Antimony toxicity","volume":"7","author":"Sundar","year":"2010","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.ejmcr.2026.100335_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/revic-2012-0006","article-title":"Chemistry of antimony-based drugs in biological systems and studies of their mechanism of action","volume":"33","author":"Fr\u00e9zard","year":"2013","journal-title":"Rev. Inorg. Chem."},{"issue":"7","key":"10.1016\/j.ejmcr.2026.100335_bib8","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"Fr\u00e9zard","year":"2009","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmcr.2026.100335_bib9","doi-asserted-by":"crossref","DOI":"10.1116\/1.4935853","article-title":"Physicochemical properties of copper important for its antibacterial activity and development of a unified model","volume":"11","author":"Hans","year":"2016","journal-title":"Biointerphases"},{"issue":"1","key":"10.1016\/j.ejmcr.2026.100335_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1039\/c8mt00262b","article-title":"Zinc finger domains as therapeutic targets for metal-based compounds \u2013 an update","volume":"11","author":"Abbehausen","year":"2019","journal-title":"Metallomics"},{"key":"10.1016\/j.ejmcr.2026.100335_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1542560","article-title":"The outcast of medicine: metals in medicine--from traditional mineral medicine to metallodrugs","volume":"16","author":"Bai","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib12","article-title":"A cytidine deaminase-like protein modulates pyrimidine nucleotide homeostasis in Trypanosoma brucei","volume":"15","author":"Moro-Bulnes","year":"2025","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ejmcr.2026.100335_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13387","article-title":"Zinc finger proteins of Plasmodium falciparum","volume":"23","author":"Ngwa","year":"2021","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib14","doi-asserted-by":"crossref","first-page":"8615","DOI":"10.3390\/ijms24108615","article-title":"Structure of Leishmania donovani 6-Phosphogluconate dehydrogenase and inhibition by phosphine Gold(I) complexes: a potential approach to leishmaniasis treatment","volume":"24","author":"Berneburg","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmcr.2026.100335_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.111726","article-title":"Antileishmanial activity and insights into the mechanisms of action of symmetric Au(I) benzyl and aryl-N-heterocyclic carbenes","volume":"229","author":"Rosa","year":"2022","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib16","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","article-title":"Recent advances and new strategies on leishmaniasis treatment","volume":"104","author":"Roatt","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib17","series-title":"Clinical Care of Leishmaniasis | Leishmaniasis","year":"2024"},{"key":"10.1016\/j.ejmcr.2026.100335_bib18","doi-asserted-by":"crossref","DOI":"10.16943\/ijhs\/2019\/v54i1\/49596","article-title":"History of science view project U N brahmachari: scientific achievements and nomination for the nobel prize and the fellowship of the royal society of London","volume":"54","author":"Singh","year":"2019","journal-title":"Indian J. Hist. Sci."},{"key":"10.1016\/j.ejmcr.2026.100335_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001227","article-title":"Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?","volume":"5","author":"Perry","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmcr.2026.100335_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmcr.2026.100335_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107190","article-title":"Insights into the trypanothione system in antimony-resistant and sensitive Leishmania tropica clinical isolates","volume":"254","author":"Valashani","year":"2024","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmcr.2026.100335_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001021","article-title":"Comparative gene expression analysis throughout the life cycle of leishmania braziliensis: diversity of expression profiles among clinical isolates","volume":"5","author":"Adaui","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmcr.2026.100335_bib23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/AAC.45.3.913-916.2001","article-title":"Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate","volume":"45","author":"Fr\u00e9zard","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmcr.2026.100335_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/695382","article-title":"Antimony resistance in leishmania, focusing on experimental research","volume":"2011","author":"Jeddi","year":"2011","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.ejmcr.2026.100335_bib25","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1021\/jm900185q","article-title":"Molecular basis of antimony treatment in leishmaniasis","volume":"52","author":"Baiocco","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20040283","article-title":"Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase","volume":"381","author":"Denton","year":"2004","journal-title":"TDR1, Biochem. J"},{"key":"10.1016\/j.ejmcr.2026.100335_bib27","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3390\/molecules25081924","article-title":"Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases","volume":"25","author":"Battista","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmcr.2026.100335_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00726-019-02731-4","article-title":"Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism","volume":"52","author":"Colotti","year":"2020","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejmcr.2026.100335_bib29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3390\/microorganisms8071069","article-title":"Can we harness immune responses to improve drug treatment in leishmaniasis?","volume":"8","author":"Aruleba","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejmcr.2026.100335_bib30","series-title":"Leishmaniasis - Trends in Epidemiology, Diagnosis and Treatment","first-page":"466","article-title":"Metal-based therapeutics for leishmaniasis","author":"Caballero","year":"2014"},{"key":"10.1016\/j.ejmcr.2026.100335_bib31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1039\/c2mt00176d","article-title":"Greater binding affinity of trivalent antimony to a CCCH zinc finger domain compared to a CCHC domain of kinetoplastid proteins","volume":"4","author":"Fr\u00e9zard","year":"2012","journal-title":"Metallomics"},{"key":"10.1016\/j.ejmcr.2026.100335_bib32","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","volume":"2011","author":"Haldar","year":"2011","journal-title":"Mol. Biol. Int."},{"key":"10.1016\/j.ejmcr.2026.100335_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0166-6851(94)90059-0","article-title":"Leishmania major HEXBP deletion mutants generated by double targeted gene replacement","volume":"63","author":"Webb","year":"1994","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib34","doi-asserted-by":"crossref","first-page":"p13994","DOI":"10.1016\/S0021-9258(19)85200-6","article-title":"Molecular cloning and expression of a Leishmania major gene encoding a single-stranded DNA-Binding protein containing nine \u2018CCHC\u2019 zinc finger motifs","volume":"268","author":"Webb","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170068","article-title":"Comprehensive identification of mRNABinding proteins of Leishmania donovani by interactome capture","volume":"12","author":"Nandan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmcr.2026.100335_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1471-2164-11-283","article-title":"Genome-wide in silico screen for CCCH-type zinc finger proteins of Trypanosoma brucei, Trypanosoma cruzi and Leishmania major","volume":"11","author":"Kramer","year":"2010","journal-title":"BMC Genom."},{"key":"10.1016\/j.ejmcr.2026.100335_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.actatropica.2015.12.016","article-title":"Visceral leishmaniasis: revisiting current treatments and approaches for future discoveries","volume":"155","author":"No","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmcr.2026.100335_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115158","article-title":"DNA topoisomerases in the unicellular protozoan parasites: unwinding the mystery","volume":"203","author":"Lamba","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10534-006-0001-4","article-title":"Characterization of reactions of antimoniate and meglumine antimoniate with a guanine ribonucleoside at different pH","volume":"19","author":"Ferreira","year":"2006","journal-title":"Biometals"},{"key":"10.1016\/j.ejmcr.2026.100335_bib40","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.jinorgbio.2005.08.015","article-title":"Complexation of antimony (SbV) with guanosine 5 0-monophosphate and guanosine 5 0-diphospho-D-mannose: formation of both mono-and bis-adducts","volume":"99","author":"Chai","year":"2005","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib41","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1089\/ars.2013.5720","article-title":"Protein tyrosine phosphatase inhibition by metals and metal complexes, antioxid","volume":"20","author":"Lu","year":"2014","journal-title":"Redox Signal"},{"key":"10.1016\/j.ejmcr.2026.100335_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.633146","article-title":"Involvement of leishmania phosphatases in parasite biology and pathogeny","volume":"11","author":"Freitas-Mesquita","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib43","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.4049\/jimmunol.167.6.3391","article-title":"Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines","volume":"167","author":"Pathak","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib44","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1128\/IAI.70.12.6589-6591.2002","article-title":"Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis","volume":"70","author":"Kocyigit","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmcr.2026.100335_bib45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.actatropica.2017.04.029","article-title":"Application of nanotechnology in treatment of leishmaniasis: a review","volume":"172","author":"Akbari","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmcr.2026.100335_bib46","article-title":"Chemotherapy used in the treatment of visceral leishmaniasis","volume":"3","author":"M\u00e1rquez","year":"2019","journal-title":"CPQ Microbiology"},{"key":"10.1016\/j.ejmcr.2026.100335_bib47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1017\/S0031182017002116","article-title":"Chemotherapeutics of visceral leishmaniasis: present and future developments","volume":"145","author":"Sundar","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmcr.2026.100335_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0974-777X.62887","article-title":"Drug resistance in leishmaniasis","volume":"2","author":"Chakravarty","year":"2010","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.ejmcr.2026.100335_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/617521","article-title":"Drug resistance in visceral leishmaniasis","volume":"2010","author":"Maltezou","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib50","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1093\/cid\/ciaa1236","article-title":"Mutations in an aquaglyceroporin as a proven marker of antimony clinical resistance in the parasite Leishmania donovani","volume":"72","author":"Potvin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmcr.2026.100335_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejmech.2018.08.012","article-title":"An update on small molecule strategies targeting leishmaniasis","volume":"157","author":"Kapil","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib52","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.3390\/ijms20225748","article-title":"An overview of drug resistance in protozoal diseases","volume":"20","author":"Capela","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmcr.2026.100335_bib53","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1017\/S0031182020002176","article-title":"A Trypanosoma cruzi zinc finger protein that is implicated in the control of epimastigote-specific gene expression and metacyclogenesis","volume":"148","author":"Tavares","year":"2021","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmcr.2026.100335_bib54","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/s12864-015-2092-1","article-title":"A bioinformatic survey of RNA-binding proteins in plasmodium","volume":"16","author":"Reddy","year":"2015","journal-title":"BMC Genom."},{"key":"10.1016\/j.ejmcr.2026.100335_bib55","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/IAI.71.4.2173-2181.2003","article-title":"Identification and characterization of a conserved, stage-specific gene product of Plasmodium falciparum recognized by parasite growth inhibitory antibodies","volume":"71","author":"Daubenberger","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmcr.2026.100335_bib56","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3390\/cells11101666","article-title":"The Plasmodium falciparum CCCH zinc finger protein ZNF4 plays an important role in gametocyte exflagellation through the regulation of Male enriched transcripts","volume":"11","author":"Hanhsen","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmcr.2026.100335_bib57","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/mmi.15215","article-title":"The Plasmodium falciparum CCCH zinc finger protein MD3 regulates male gametocytogenesis through its interaction with RNA-binding proteins","volume":"121","author":"Farrukh","year":"2024","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib58","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.3390\/ijms26125470","article-title":"The Plasmodium falciparum RING finger protein PfRNF1 forms an interaction network with regulators of sexual development","volume":"26","author":"Farrukh","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmcr.2026.100335_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12936-024-04839-9","article-title":"Characterization of a nuclear transport factor 2-like domain-containing protein in Plasmodium berghei","volume":"23","author":"Niikura","year":"2024","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmcr.2026.100335_bib60","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/pathogens12101232","article-title":"Functional characterization of eight zinc finger motif-containing proteins in Toxoplasma gondii type I RH strain using the CRISPR-Cas9 system","volume":"12","author":"Gao","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmcr.2026.100335_bib61","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3389\/fmicb.2015.00975","article-title":"New drug target in protozoan parasites: the role of thioredoxin reductase","volume":"6","author":"Andrade","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biochi.2019.03.015","article-title":"Repurposing of auranofin: thioredoxin reductase remains a primary target of the drug","volume":"162","author":"Zhang","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmcr.2026.100335_bib63","doi-asserted-by":"crossref","first-page":"28977","DOI":"10.1074\/jbc.M109.020701","article-title":"Inhibition of Schistosoma mansoni Thioredoxin-glutathione reductase by auranofin: structural and kinetic aspects","volume":"284","author":"Angelucci","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib64","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.3390\/molecules25215075","article-title":"Repurposing auranofin and evaluation of a new Gold(I) compound for the search of treatment of human and cattle parasitic diseases: from protozoa to helminth infections","volume":"25","author":"Feng","year":"2020","journal-title":"Mol"},{"key":"10.1016\/j.ejmcr.2026.100335_bib65","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jsb.2016.02.015","article-title":"X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of auranofin action","volume":"194","author":"Parsonage","year":"2016","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib66","article-title":"Phase I clinical trial results of auranofin, a novel antiparasitic agent","volume":"61","author":"Capparelli","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmcr.2026.100335_bib67","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.febslet.2008.02.028","article-title":"New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: mechanistic and pharmacological implications","volume":"582","author":"Sannella","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmcr.2026.100335_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.618994","article-title":"Auranofin resistance in Toxoplasma gondii decreases the accumulation of reactive oxygen species but does not target parasite thioredoxin reductase","volume":"11","author":"Ma","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002973","article-title":"Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis","volume":"8","author":"Andrade","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmcr.2026.100335_bib70","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00726-011-0997-9","article-title":"A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition","volume":"2\u20133","author":"Ilari","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejmcr.2026.100335_bib71","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1021\/cb400800q","article-title":"Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity","volume":"9","author":"Sharlow","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib72","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1021\/acsinfecdis.9b00505","article-title":"Preclinical gold complexes as oral drug candidates to treat leishmaniasis are potent trypanothione reductase inhibitors","volume":"6","author":"Tunes","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmcr.2026.100335_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900363","article-title":"Evaluation of the antiparasitic activities of imidazole-2-ylidene\u2013gold(I) complexes","volume":"353","author":"Koko","year":"2020","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmcr.2026.100335_bib74","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molbiopara.2017.05.001","article-title":"Anti-trypanosomal activity of cationic N-heterocyclic carbene gold(I) complexes","volume":"214","author":"Winter","year":"2017","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116716","article-title":"An organogold compound impairs Leishmania amazonensis amastigotes survival and delays lesion progression in murine cutaneous leishmaniasis: mechanistic insights","volume":"232","author":"Minori","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib76","doi-asserted-by":"crossref","first-page":"11903","DOI":"10.1039\/D4DT01458H","article-title":"Structure-activity relationship of anticancer and antiplasmodial gold bis(dithiolene) complexes","volume":"53","author":"Vitr\u00e9","year":"2024","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmcr.2026.100335_bib77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/polym14020279","article-title":"Comparative investigation of cellular effects of polyethylene glycol (PEG) derivatives","volume":"14","author":"Le Khanh","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.ejmcr.2026.100335_bib78","doi-asserted-by":"crossref","first-page":"11280","DOI":"10.1021\/ic401535s","article-title":"Gold(I)-phosphine-N-heterocycles: biological activity and specific (ligand) interactions on the C-terminal HIVNCp7 zinc finger","volume":"52","author":"Abbehausen","year":"2013","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib79","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1021\/acs.inorgchem.5b00360","article-title":"Reactivity of Cys4 zinc finger domains with gold(III) complexes: insights into the formation of \u2018gold fingers\u2019","volume":"54","author":"Jacques","year":"2015","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib80","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1002\/chem.201901535","article-title":"Cyclometalated AuIII complexes for cysteine arylation in zinc finger protein domains: towards controlled reductive elimination","volume":"25","author":"Wenzel","year":"2019","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmcr.2026.100335_bib81","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.3390\/molecules24193604","article-title":"Ferrocene-based compounds with antimalaria\/anticancer activity","volume":"24","author":"Peter","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmcr.2026.100335_bib82","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/ml1002629","article-title":"Inhibitory effect of silver nanoparticles on trypanothione reductase activity and Leishmania infantum proliferation","volume":"2","author":"Baiocco","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmcr.2026.100335_bib83","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00775-019-01657-2","article-title":"Synthesis and evaluation of the antileishmanial activity of silver compounds containing imidazolidine-2-thione","volume":"24","author":"Espuri","year":"2019","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2016.10.004","article-title":"Novel metalloantimalarials: transmission blocking effects of water soluble Cu(I), Ag(I) and Au(I) phosphane complexes on the murine malaria parasite Plasmodium berghei","volume":"166","author":"Tapanelli","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.112047","article-title":"Silver and copper-benznidazole derivatives as potential antiparasitic metallodrugs: synthesis, characterization, and biological evaluation","volume":"239","author":"De Souza","year":"2023","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib86","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1021\/acs.inorgchem.8b02201","article-title":"Ni(II), Hg(II), and Pb(II) coordination in the prokaryotic zinc-finger Ros87","volume":"58","author":"Sivo","year":"2019","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib87","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/inorganics11020064","article-title":"Interactions of an artificial zinc finger protein with Cd(II) and Hg(II): competition and metal and DNA binding","volume":"11","author":"Hajdu","year":"2023","journal-title":"INORGA"},{"key":"10.1016\/j.ejmcr.2026.100335_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202304064","article-title":"Inducing \u03b1-Helicity in peptides by silver coordination to cysteine","volume":"30","author":"Fischer","year":"2024","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmcr.2026.100335_bib89","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jinorgbio.2019.03.012","article-title":"Antigiardiasic activity of Cu(II) coordination compounds: redox imbalance and membrane damage after a short exposure time","volume":"195","author":"Rufino-Gonz\u00e1lez","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib90","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jinorgbio.2012.01.010","article-title":"New achievements on biological aspects of copper complexes casiope\u00ednas\u00ae: interaction with DNA and proteins and anti-trypanosoma cruzi activity","volume":"109","author":"Becco","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib91","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000538360","article-title":"Casiopeina III-ia: a copper compound with potential use for treatment of infections caused by Leishmania mexicana","volume":"69","author":"Delgado-Dom\u00ednguez","year":"2024","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ejmcr.2026.100335_bib92","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12936-022-04406-0","article-title":"Dinuclear and mononuclear metal(II) polypyridyl complexes against drug-sensitive and drug-resistant Plasmodium falciparum and their mode of action","volume":"21","author":"Lai","year":"2022","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmcr.2026.100335_bib93","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00775-023-02029-7","article-title":"Anti-toxoplasma activity and DNA-binding of copper(II) and zinc(II) coordination compounds with 5-nitroimidazole-based ligands","volume":"29","author":"Navarro-Pe\u00f1aloza","year":"2024","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911010","article-title":"Copper (I) or (II) replacement of the structural zinc ion in the prokaryotic zinc finger ros does not result in a functional domain","volume":"23","author":"Dragone","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmcr.2026.100335_bib95","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00775-020-01779-y","article-title":"Multi-target heteroleptic palladium bisphosphonate complexes","volume":"25","author":"Cipriani","year":"2020","journal-title":"JBIC, J. Biol. Inorg. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.111906","article-title":"Cytotoxic and antiparasitic activities of diphosphine-metal complexes of group 10 containing acylthiourea as ligands","volume":"234","author":"De Oliveira","year":"2022","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202300158","article-title":"Synthesis, characterization, antimicrobial and antimalarial activities of azines based schiff bases and their Pd(II) complexes","volume":"20","author":"Meena","year":"2023","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmcr.2026.100335_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.112117","article-title":"Reactivity of NiII, PdII and PtII complexes bearing phosphine ligands towards ZnII displacement and hydrolysis in Cis2His2 and Cis3His zinc-fingers domains","volume":"240","author":"Galuppo","year":"2023","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib99","first-page":"2028","article-title":"In-vitro and In-vivo antileishmanial activity of a compound derived of platinum, oxaliplatin, against Leishmania major","volume":"18","author":"Ghasemi","year":"2019","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"key":"10.1016\/j.ejmcr.2026.100335_bib100","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1039\/D0DT03963B","article-title":"New Pd\u2013Fe ferrocenyl antiparasitic compounds with bioactive 8-hydroxyquinoline ligands: a comparative study with their Pt\u2013Fe analogues","volume":"50","author":"Rivas","year":"2021","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmcr.2026.100335_bib101","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1021\/acsmedchemlett.4c00545","article-title":"Synthesis and SAR studies of acyl-thiourea Platinum(II) complexes yield analogs with dual-stage antiplasmodium activity","volume":"16","author":"Ishmail","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmcr.2026.100335_bib102","doi-asserted-by":"crossref","DOI":"10.1093\/mtomcs\/mfac061","article-title":"Comparative cisplatin reactivity towards human Zn7-metallothionein-2 and MTF-1 zinc fingers: potential implications in anticancer drug resistance","volume":"14","author":"Bulathge","year":"2022","journal-title":"Metallomics"},{"key":"10.1016\/j.ejmcr.2026.100335_bib103","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1002\/ejic.202100402","article-title":"Targeting zinc finger proteins with exogenous metals and molecules: lessons learned from tristetraprolin, a CCCH type zinc finger","volume":"37","author":"Ok","year":"2021","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib104","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.2147\/DDDT.S275007","article-title":"Ruthenium complexes as anticancer agents: a brief history and perspectives","volume":"14","author":"Lee","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmcr.2026.100335_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910787","article-title":"Cellular and molecular targets of nucleotide-tagged trithiolato-bridged arene ruthenium complexes in the protozoan parasites toxoplasma gondii and trypanosoma brucei","volume":"22","author":"Anghel","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmcr.2026.100335_bib106","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1021\/acs.inorgchem.4c01125","article-title":"Multifunctional organometallic compounds active against infective trypanosomes: ru(ii) ferrocenyl derivatives with two different bioactive ligands","volume":"63","author":"Rivas","year":"2024","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2025.107639","article-title":"In silico, in vitro, and in vivo assessment of Anti-Trypanosoma cruzi activity of the 1H-indazole-containing ruthenium complex FOR0E2","volume":"266","author":"Cezar","year":"2025","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmcr.2026.100335_bib108","doi-asserted-by":"crossref","first-page":"12722","DOI":"10.1021\/acs.inorgchem.0c01795","article-title":"Half-Sandwich Cyclopentadienylruthenium(II) complexes: a new antimalarial chemotype","volume":"59","author":"Milheiro","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib109","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3390\/molecules28031359","article-title":"Evaluation of Ruthenium(II) N-Heterocyclic carbene complexes as enzymatic inhibitory agents with antioxidant, antimicrobial, antiparasitical and antiproliferative activity","volume":"28","author":"Al Nasr","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmcr.2026.100335_bib110","first-page":"1182","article-title":"Targeting trypanothione synthetase and trypanothione reductase: development of common inhibitors to tackle trypanosomatid disease","volume":"18","author":"Augusto","year":"2025","journal-title":"Pharm. Times"},{"key":"10.1016\/j.ejmcr.2026.100335_bib111","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/14756366.2016.1250755","article-title":"Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives","volume":"32","author":"Saccoliti","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib112","article-title":"Synthesis and structure of novel Pyrimidine-Thioethers: structural effects on reactivity along with an unpredicted dimethylamination reaction","volume":"00","author":"Costa","year":"2025","journal-title":"ChemPhysChem"},{"key":"10.1016\/j.ejmcr.2026.100335_bib113","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/acsinfecdis.2c00325","article-title":"Optimization of potent and specific trypanothione reductase inhibitors: a structure-based drug discovery approach","volume":"8","author":"Battista","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmcr.2026.100335_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006969","article-title":"Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening","volume":"12","author":"Turcano","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmcr.2026.100335_bib115","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1021\/acs.jmedchem.1c00206","article-title":"Efficient dimerization disruption of Leishmania infantum trypanothione reductase by triazole-phenyl-thiazoles","volume":"64","author":"Alejandro","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib116","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1128\/AAC.49.12.4950-4956.2005","article-title":"Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases","volume":"49","author":"Nakayama","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmcr.2026.100335_bib117","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3390\/ijms24021635","article-title":"Miltefosine and nifuratel combination: a promising therapy for the treatment of Leishmania donovani visceral leishmaniasis","volume":"24","author":"Melcon-Fernandez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmcr.2026.100335_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/ange.202203064","article-title":"Organic four-electron Redox systems based on bipyridine and phenanthroline carbene architectures","volume":"134","author":"Antoni","year":"2022","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib119","doi-asserted-by":"crossref","first-page":"27016","DOI":"10.1039\/C9TA08910A","article-title":"Structure reorganization-controlled electron transfer of bipyridine derivatives as organic redox couples","volume":"7","author":"Lv","year":"2019","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ejmcr.2026.100335_bib120","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1021\/acscatal.2c02655","article-title":"Ligand-Based redox: catalytic applications and mechanistic aspects","volume":"12","author":"Singh","year":"2022","journal-title":"ACS Catal."},{"key":"10.1016\/j.ejmcr.2026.100335_bib121","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/17460441.2016.1135125","article-title":"An overview of molecular hybrids in drug discovery","volume":"11","author":"B\u00e9rub\u00e9","year":"2016","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmcr.2026.100335_bib122","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1051\/parasite\/2000072103","article-title":"In vivo antileishmanial action of Ir-(COD)-pentamidine tetraphenylborate on Leishmania donovani and Leishmania major mouse models","volume":"7","author":"Loiseau","year":"2000","journal-title":"Parasite"},{"key":"10.1016\/j.ejmcr.2026.100335_bib123","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1365-3156.1997.d01-128.x","article-title":"Trypanocidal effect of Ir-(COD)-pentamidine tetraphenylborate on Trypanosoma brucei and T. b. gambiense rodent models and serum kinetics in sheep","volume":"2","author":"Loiseau","year":"1997","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ejmcr.2026.100335_bib124","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1179\/joc.2001.13.1.59","article-title":"Antitrypanosomal properties of cis-platinum-pentamidine bromide, thiocyanate and seleniocyanate on Trypanosoma brucei brucei mouse and sheep models","volume":"13","author":"Loiseau","year":"2001","journal-title":"J. Chemother."},{"key":"10.1016\/j.ejmcr.2026.100335_bib125","first-page":"850","article-title":"Uptake into Leishmania donovani promastigotes and antileishmanial action of an organometallic complex derived from pentamidine","volume":"48","author":"Mbongo","year":"1998","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.ejmcr.2026.100335_bib126","first-page":"110","article-title":"Pharmacomodulations on new organometallic complexes of Ir, Pt, Rh, Pd, Os: in vitro and in vivo trypanocidal study against Trypanosoma brucei brucei","volume":"43","author":"Loiseau","year":"1992","journal-title":"Trop. Med. Parasitol."},{"key":"10.1016\/j.ejmcr.2026.100335_bib127","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s004360050290","article-title":"In vitro sensitivity of Leishmania donovani to organometallic derivatives of pentamidine","volume":"83","author":"Mbongo","year":"1997","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmcr.2026.100335_bib128","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s004360100400","article-title":"Structure-activity relationships for new organometallic complexes active against bloodstream forms of Trypanosoma brucei brucei","volume":"87","author":"Loiseau","year":"2001","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmcr.2026.100335_bib129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0001-706X(98)00018-7","article-title":"Synergistic effect of Ir-(COT)-pentamidine alizarin red and pentamidine, amphotericin B, and paromomycin on Leishmania donovani","volume":"70","author":"Mbongo","year":"1998","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmcr.2026.100335_bib130","first-page":"41","article-title":"Trypanosoma brucei brucei: antitrypanosomal evaluation of stilbamidinium hexachloroiridiate on the murine CNS model and iridium serum kinetics in infected sheep","volume":"46","author":"Dreyfuss","year":"1995","journal-title":"Trop. Med. Parasitol."}],"container-title":["European Journal of Medicinal Chemistry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772417426000142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772417426000142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:32:42Z","timestamp":1776429162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772417426000142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":130,"alternative-id":["S2772417426000142"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmcr.2026.100335","relation":{},"ISSN":["2772-4174"],"issn-type":[{"value":"2772-4174","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding the role of thiophilic metallodrugs in antiparasitic chemotherapy: multi-target approaches against protozoan parasites","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmcr.2026.100335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"100335"}}